Quidel (QDEL -0.6%) gets FDA 501(k) clearance for its immunoassay system for the detection of...

|About: Quidel Corporation (QDEL)|By:, SA News Editor

Quidel (QDEL -0.6%) gets FDA 501(k) clearance for its immunoassay system for the detection of Strep A. CEO Douglas Bryant says he is pleased that customers will now have access to "an easy-to-use, fast and accurate solution for the diagnosis of Strep A," and notes that the news is just "another catalyst for increasing Sofia placements in the field." Sofia is the brand name for the immunoassay system. (PR)